Neutralisation of adeno-associated virus transduction by human vitreous humour
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neutralisation of adeno-associated virus transduction by human vitreous humour
Authors
Keywords
-
Journal
GENE THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-15
DOI
10.1038/s41434-020-0162-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adeno-associated virus neutralising antibodies in type 1 diabetes mellitus
- (2019) Slawomir Andrzejewski et al. GENE THERAPY
- Relationship Between Neutralizing Antibodies Against Adeno-Associated Virus in the Vitreous and Serum: Effects on Retinal Gene Therapy
- (2019) Suhwan Lee et al. Translational Vision Science & Technology
- AAV8 virions hijack serum proteins to increase hepatocyte binding for transduction enhancement
- (2018) Xiaolei Pei et al. VIROLOGY
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy
- (2018) Pasqualina Colella et al. Molecular Therapy-Methods & Clinical Development
- AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
- (2018) Jérôme Denard et al. Molecular Therapy-Methods & Clinical Development
- Gene therapy and the adeno-associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations
- (2018) Charmaine A. Ramlogan-Steel et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye
- (2018) Gerard A. Rodrigues et al. PHARMACEUTICAL RESEARCH
- The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens
- (2017) Laura Díaz-Alvarez et al. MEDIATORS OF INFLAMMATION
- Proteome-wide Identification of Glycosylation-dependent Interactors of Galectin-1 and Galectin-3 on Mesenchymal Retinal Pigment Epithelial (RPE) Cells
- (2017) Jara Obermann et al. MOLECULAR & CELLULAR PROTEOMICS
- First AAV gene therapy poised for landmark approval
- (2017) Eric Smalley NATURE BIOTECHNOLOGY
- Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy
- (2016) Gabriela de Moraes et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Direct interaction of human serum proteins with AAV virions to enhance AAV transduction: immediate impact on clinical applications
- (2016) M Wang et al. GENE THERAPY
- High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence
- (2016) Daniela Hüser et al. JOURNAL OF VIROLOGY
- Proteomic Analysis of Vitreous Humor in Retinal Vein Occlusion
- (2016) Michael Reich et al. PLoS One
- Vitreous humor analysis for the detection of xenobiotics in forensic toxicology: a review
- (2015) Fabien Bévalot et al. Forensic Toxicology
- Laboratory support in the diagnosis of uveitis
- (2013) Jyotirmay Biswas et al. INDIAN JOURNAL OF OPHTHALMOLOGY
- Human Galectin 3 Binding Protein Interacts with Recombinant Adeno-Associated Virus Type 6
- (2012) J. Denard et al. JOURNAL OF VIROLOGY
- Proteomic Analyses of the Vitreous Humour
- (2012) Martina Angi et al. MEDIATORS OF INFLAMMATION
- Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia
- (2011) C Li et al. GENE THERAPY
- Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5
- (2011) C. E. Harbison et al. JOURNAL OF GENERAL VIROLOGY
- Neutralizing Antibodies Against AAV Serotypes 1, 2, 6, and 9 in Sera of Commonly Used Animal Models
- (2011) Kleopatra Rapti et al. MOLECULAR THERAPY
- INTRAOCULAR PHARMACOKINETICS AFTER A SINGLE INTRAVITREAL INJECTION OF 1.5 mg VERSUS 3.0 mg OF BEVACIZUMAB IN HUMANS
- (2011) Carsten H Meyer et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Expression and distribution of immunoglobulin G and its receptors in an immune privileged site: the eye
- (2010) Na Niu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular Degeneration
- (2010) Timothy K MacLachlan et al. MOLECULAR THERAPY
- Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated Viruses
- (2009) Roberto Calcedo et al. JOURNAL OF INFECTIOUS DISEASES
- Inner Limiting Membrane Barriers to AAV-mediated Retinal Transduction From the Vitreous
- (2009) Deniz Dalkara et al. MOLECULAR THERAPY
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
- (2008) Carl D. Regillo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Adult vitreous structure and postnatal changes
- (2008) M M Le Goff et al. EYE
- Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils
- (2008) A. Karlsson et al. GLYCOBIOLOGY
- Complement Is an Essential Component of the Immune Response to Adeno-Associated Virus Vectors
- (2008) A. K. Zaiss et al. JOURNAL OF VIROLOGY
- Ocular Manifestations Associated with Chikungunya
- (2007) Padmamalini Mahendradas et al. OPHTHALMOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More